Notably, the prostate lesions in the Parp-1−/− model group were significantly milder than those in the WT model group, suggesting that PARP1 might play a role in regulating the process of prostate inflammation (Fig. 2C). This evidence concerns the gene PARP1 and urogenital neoplasm.